Compare Pfizer with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs FRESENIUS KABI ONCO. - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER FRESENIUS KABI ONCO. PFIZER/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 48.8 22.1 220.4% View Chart
P/BV x 8.1 3.1 260.1% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 PFIZER   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    PFIZER
Mar-19
FRESENIUS KABI ONCO.
Mar-13
PFIZER/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs3,840176 2,181.8%   
Low Rs2,08079 2,649.7%   
Sales per share (Unadj.) Rs455.037.7 1,207.3%  
Earnings per share (Unadj.) Rs93.85.1 1,841.3%  
Cash flow per share (Unadj.) Rs109.46.7 1,627.0%  
Dividends per share (Unadj.) Rs22.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs658.242.5 1,547.1%  
Shares outstanding (eoy) m45.75158.23 28.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.53.4 192.7%   
Avg P/E ratio x31.625.0 126.3%  
P/CF ratio (eoy) x27.118.9 143.0%  
Price / Book Value ratio x4.53.0 150.4%  
Dividend payout %24.00-   
Avg Mkt Cap Rs m135,42020,135 672.6%   
No. of employees `0002.61.2 228.4%   
Total wages/salary Rs m3,238703 460.5%   
Avg. sales/employee Rs Th7,911.45,176.2 152.8%   
Avg. wages/employee Rs Th1,230.9610.4 201.6%   
Avg. net profit/employee Rs Th1,630.7699.6 233.1%   
INCOME DATA
Net Sales Rs m20,8155,963 349.1%  
Other income Rs m1,67418 9,299.4%   
Total revenues Rs m22,4895,981 376.0%   
Gross profit Rs m5,7121,430 399.4%  
Depreciation Rs m714258 276.8%   
Interest Rs m73-26 -280.4%   
Profit before tax Rs m6,5991,216 542.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m2,309342 674.6%   
Profit after tax Rs m4,291806 532.4%  
Gross profit margin %27.424.0 114.4%  
Effective tax rate %35.028.1 124.3%   
Net profit margin %20.613.5 152.5%  
BALANCE SHEET DATA
Current assets Rs m27,1675,102 532.5%   
Current liabilities Rs m8,9172,385 373.8%   
Net working cap to sales %87.745.6 192.5%  
Current ratio x3.02.1 142.5%  
Inventory Days Days68150 45.2%  
Debtors Days Days30113 26.6%  
Net fixed assets Rs m8,8625,148 172.1%   
Share capital Rs m458158 289.2%   
"Free" reserves Rs m29,6566,556 452.4%   
Net worth Rs m30,1136,732 447.3%   
Long term debt Rs m25952 2.6%   
Total assets Rs m39,40010,388 379.3%  
Interest coverage x91.5-45.8 -199.9%   
Debt to equity ratio x00.1 0.6%  
Sales to assets ratio x0.50.6 92.0%   
Return on assets %11.17.5 147.5%  
Return on equity %14.212.0 119.0%  
Return on capital %22.114.6 151.6%  
Exports to sales %074.5 0.0%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m4285,298 8.1%   
Fx outflow Rs m7861,772 44.4%   
Net fx Rs m-3583,525 -10.2%   
CASH FLOW
From Operations Rs m9781,274 76.8%  
From Investments Rs m351-1,204 -29.2%  
From Financial Activity Rs m-1,099-196 560.2%  
Net Cashflow Rs m231-126 -182.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 81.0 78.9%  
Indian inst/Mut Fund % 7.5 0.3 2,500.0%  
FIIs % 4.9 9.6 51.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 9.1 260.4%  
Shareholders   85,207 42,599 200.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALEMBIC  SUN PHARMA  IPCA LABS  FDC  AUROBINDO PHARMA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 7, 2021 (Close)

TRACK PFIZER

PFIZER - FULFORD INDIA COMPARISON

COMPARE PFIZER WITH

MARKET STATS